Edition:
United States

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

105.80USD
15 Jun 2018
Change (% chg)

$-0.96 (-0.90%)
Prev Close
$106.76
Open
$106.76
Day's High
$106.76
Day's Low
$105.25
Volume
411,571
Avg. Vol
204,894
52-wk High
$107.61
52-wk Low
$71.29

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $15,101.72
Shares Outstanding(Mil.): 142.74
Dividend: 0.35
Yield (%): 1.32

Financials

  RMD.N Industry Sector
P/E (TTM): 34.55 38.09 34.18
EPS (TTM): 3.06 -- --
ROI: 14.27 8.73 13.17
ROE: 22.42 12.61 15.15

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

Apr 26 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

Apr 19 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

Apr 02 2018

BRIEF-ResMed Q2 Gaap Earnings Per Share $0.07

* ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018

Jan 22 2018

Earnings vs. Estimates